Estrogen Replacement Therapy

"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Descriptor ID	D015914
MeSH Number(s)	E02.319.452.150
Concept/Terms	Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogen Replacement Therapies Replacement Therapies, Estrogen Therapies, Estrogen Replacement Therapy, Estrogen Replacement Replacement Therapy, Estrogen Estrogen Replacement Estrogen Replacement Estrogen Replacements Replacements, Estrogen Replacement, Estrogen Postmenopausal Hormone Replacement Therapy Postmenopausal Hormone Replacement Therapy Hormone Replacement Therapy, Post-Menopausal Hormone Replacement Therapy, Post Menopausal Estrogen Progestin Replacement Therapy Estrogen Progestin Replacement Therapy Estrogen Progestin Combination Therapy

Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Hormone Replacement Therapy [E02.319.452]
Estrogen Replacement Therapy [E02.319.452.150]

Below are MeSH descriptors whose meaning is related to "Estrogen Replacement Therapy".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.

Bar chart showing 42 publications over 18 distinct years, with a maximum of 4 publications in 2002 and 2004 and 2007 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	0	3
1997	0	2	2
1999	0	1	1
2000	2	0	2
2001	0	1	1
2002	3	1	4
2003	1	0	1
2004	3	1	4
2005	2	1	3
2006	1	2	3
2007	2	2	4
2008	1	2	3
2009	0	1	1
2010	0	2	2
2013	0	1	1
2014	0	2	2
2015	3	1	4
2019	1	0	1

Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.

Sarink D, Yang J, Johnson T, Chang-Claude J, Overvad K, Olsen A, Tj?nneland A, Fournier A, Mancini FR, Kvaskoff M, Boeing H, Trichopoulou A, Karakatsani A, Valanou E, Agnoli C, Sacerdote C, Masala G, Mattiello A, Tumino R, Van Gils CH, Skeie G, Gram IT, Weiderpass E, Lujan-Barroso L, Petrova D, Santiuste C, Quir?s JR, Barricarte A, Amiano P, Travis RC, Gunter M, Dossus L, Christakoudi S, Kaaks R, Fortner RT. Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort. Cancer Epidemiol Biomarkers Prev. 2019 10; 28(10):1746-1754.

View in: PubMed
Be?evic J, Gunter MJ, Fortner RT, Tsilidis KK, Weiderpass E, Onland-Moret NC, Dossus L, Tj?nneland A, Hansen L, Overvad K, Mesrine S, Baglietto L, Clavel-Chapelon F, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Agnoli C, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Peeters PH, Jareid M, Quir?s JR, Duell EJ, S?nchez MJ, Larra?aga N, Chirlaque MD, Barricarte A, Dias JA, Sonestedt E, Idahl A, Lundin E, Wareham NJ, Khaw KT, Travis RC, Rinaldi S, Romieu I, Riboli E, Merritt MA. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study. Br J Cancer. 2015 Dec 01; 113(11):1622-31.

View in: PubMed
Ding M, Franke AA, Rosner BA, Giovannucci E, van Dam RM, Tworoger SS, Hu FB, Sun Q. Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women. Br J Nutr. 2015 Nov 28; 114(10):1694-701.

View in: PubMed
Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM. Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology. 2015 Sep 29; 85(13):1131-8.

View in: PubMed
Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell FA, Kooperberg C, Manson JE, O'Sullivan MJ, Rohan T, Stefanick ML, Wactawski-Wende J, Wakelee H, Simon MS. Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies. J Thorac Oncol. 2015 Jul; 10(7):1004-13.

View in: PubMed
Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014 Sep; 66(4):602-18.

View in: PubMed
Fontenot HB, Harris AL. Pharmacologic management of osteoporosis. J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr; 43(2):236-45; quiz E20-1.

View in: PubMed
Bell CL, LaCroix A, Masaki K, Hade EM, Manini T, Mysiw WJ, Curb JD, Wassertheil-Smoller S. Prestroke factors associated with poststroke mortality and recovery in older women in the Women's Health Initiative. J Am Geriatr Soc. 2013 Aug; 61(8):1324-30.

View in: PubMed
Lee E, Maneno MK, Wutoh AK, Zuckerman IH. Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing. J Womens Health (Larchmt). 2010 May; 19(5):847-54.

View in: PubMed
Sun WL, Luine VN, Zhou L, Wu HB, Weierstall KM, Jenab S, Qui?iones-Jenab V. Acute progesterone treatment impairs spatial working memory in intact male and female rats. Ethn Dis. 2010; 20(1 Suppl 1):S1-83-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals